Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer
NCT01149174
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
352
Enrollment
OTHER
Sponsor class
Conditions
Superficial Bladder Cancer
Interventions
DRUG:
Mitomycin-C 40 mg
Sponsor
University of Rome Tor Vergata